InvestorsHub Logo
Followers 14
Posts 2972
Boards Moderated 0
Alias Born 07/19/2006

Re: gfp927z post# 37182

Friday, 06/10/2011 7:23:27 AM

Friday, June 10, 2011 7:23:27 AM

Post# of 52305
From the archives:

<<<In July 2007, the Neurology Division removed the dosing restrictions, and allowed us to resume our clinical trial with CX717 in Alzheimer’s disease at all dose levels requested prior to the hold being placed on the compound.>>>

This may be the defining moment which catapulted this company into their 'Four years of Failure'. This feels like it did in 2004 under Bush. Please, not another four years! Or one more for that matter...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News